BQPrime
•77% Informative
Management has started commercial supply of Antioxida India AOs) which should start contributing to revenues in 1Q FY24. Original DISCLAIMER Motilal Oswal Report summaryFeed_highLightText__NxlGi">BUY 6% FY25E EPS 35x 50.3% xlGi">2.4xQoQ > EBITDAM "sum 30.3% eed_highLightText__NxlGi">20-23% IBB d_highLightText__NxlGi">FY25E EV/EBITDA 21x FY25E EPS 28x < Antioxidants summaryFeed_highLightText__NxlGi">the same period 26%/24% 26.5%/ 27.3% EBITDAM50% 40ktpa to 60ktpa ed_highLightText__NxlGi">18%/ 17% 12%/ the year __NxlGi">12%/ 19%/18% VOL i">PAT Guaiacol span Iso Amylene aryFeed_highLightText__NxlGi">9% < 1HFY24 lass="summaryFeed_highLightText__NxlGi">IB & HPMTBE< 44% an> IBB sp 19% cla Butyl Phenol eed_highLig IB Text__NxlGi">7 16% spa Customized
VR Score
84
Informative language
87
Neutral language
86
Article tone
formal
Language
English
Language complexity
36
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links